Chemours (CC) Tops Q3 EPS by 28c; adj.-EBITDA Rose ~59%

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/14/2026

1. DPZ
2. LQDA
3. BAC
4. VSTM
5. UNH
6. GS
7. JPM
8. WDAY
9. FAST
10. FFAI

Go back to Chemours (CC) Tops Q3 EPS by 28c; adj.-EBITDA Rose ~59%

The Chemours Company Reports Third Quarter 2016 Results; Significant Earnings and Margins Increases Driven by Progress on Transformation Plan and Improved Market Conditions

November 6, 2016 4:30 PM EST

WILMINGTON, Del., Nov. 6, 2016 /PRNewswire/ --

Third Quarter 2016 Highlights

Net Sales of $1.4 billion Net Income of $204 million, or $1.11 per diluted share, including gain on asset sales of $169 million, impairment charges of $46 million, interest expense of $51 million and restructuring costs of $14 million Adjusted EBITDA of $268 million Adjusted Net Income of $112 million, or $0.61 per diluted share

Other Highlights

Continued progress on all transformation plan objectives, including cost reductions, growth initiatives and portfolio rationalization Improved cash from operating activities by ~$440 million year-to-date Retired $315 million of long term... More